Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability

Heli J. Lehtonen, Markus J. Mäkinen, Maija Ht Kiuru, Päivi Laiho, Riitta Herva, Ivonne Van Minderhout, Pancras C.W. Hogendoorn, Cees Cornelisse, Peter Devilee, Virpi Launonen, Lauri A. Aaltonen

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Germline mutations in nuclear genes encoding mitochondrial enzymes fumarate hydratase (FH) and succinate dehydrogenase (subunits SDHB/C/D) have been implicated in the development of tumor syndromes referred to as hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary paragangliomatosis (HPGL), respectively. FH and SDH are operating in the tricarboxylic acid cycle (the TCA cycle, the Krebs cycle). In the FH and SDH deficient tumors, accumulation of the substrates, fumarate and succinate, has been shown to cause stabilization of hypoxia inducible factor 1α (HIF1α). According to recent studies, HIF1α could contribute to the hypoxia induced genomic instability seen in many cancers, through repression of mismatch repair (MMR) protein MSH2. In this study, in agreement with previous works, we found HIF1α to be moderately or highly stabilized in 67% (16/24) and 77% (48/62) of HLRCC tumors and SDHB/C/D paragangliomas (PGL) and pheochromocytomas (PHEO), respectively. In addition, a set of 54 other familial and nonfamilial PGLs/PHEOs were studied. Moderately or highly stabilized HIF1α was present in 68% (26/38) of the PGLs but in PHEOs (n = 16) no such pattern was observed. We then analyzed the suggested link between HIF1α stabilization and MSH2 repression, in HLRCC and HPGL tumor material. No microsatellite instability (MSI) or lack of MSH2 expression was, however, observed. Thus we failed to provide in vivo evidence for the proposed link between HIF1α stabilization and functional MMR deficiency, in TCAC deficient tumors.

Original languageEnglish (US)
Pages (from-to)1386-1389
Number of pages4
JournalInternational Journal of Cancer
Volume121
Issue number6
DOIs
StatePublished - Sep 15 2007
Externally publishedYes

Fingerprint

Fumarate Hydratase
Hypoxia-Inducible Factor 1
Microsatellite Instability
Neoplasms
Citric Acid Cycle
Paraganglioma
Fumarates
DNA Mismatch Repair
Mitochondrial Genes
Succinate Dehydrogenase
Germ-Line Mutation
Genomic Instability
Succinic Acid
Pheochromocytoma
Enzymes

Keywords

  • Fumarate hydratase
  • HIF1
  • Microsatellite instability
  • MSH2
  • Succinate dehydrogenase

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Lehtonen, H. J., Mäkinen, M. J., Kiuru, M. H., Laiho, P., Herva, R., Van Minderhout, I., ... Aaltonen, L. A. (2007). Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability. International Journal of Cancer, 121(6), 1386-1389. https://doi.org/10.1002/ijc.22819

Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability. / Lehtonen, Heli J.; Mäkinen, Markus J.; Kiuru, Maija Ht; Laiho, Päivi; Herva, Riitta; Van Minderhout, Ivonne; Hogendoorn, Pancras C.W.; Cornelisse, Cees; Devilee, Peter; Launonen, Virpi; Aaltonen, Lauri A.

In: International Journal of Cancer, Vol. 121, No. 6, 15.09.2007, p. 1386-1389.

Research output: Contribution to journalArticle

Lehtonen, HJ, Mäkinen, MJ, Kiuru, MH, Laiho, P, Herva, R, Van Minderhout, I, Hogendoorn, PCW, Cornelisse, C, Devilee, P, Launonen, V & Aaltonen, LA 2007, 'Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability', International Journal of Cancer, vol. 121, no. 6, pp. 1386-1389. https://doi.org/10.1002/ijc.22819
Lehtonen, Heli J. ; Mäkinen, Markus J. ; Kiuru, Maija Ht ; Laiho, Päivi ; Herva, Riitta ; Van Minderhout, Ivonne ; Hogendoorn, Pancras C.W. ; Cornelisse, Cees ; Devilee, Peter ; Launonen, Virpi ; Aaltonen, Lauri A. / Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability. In: International Journal of Cancer. 2007 ; Vol. 121, No. 6. pp. 1386-1389.
@article{5661542859fd41a7b70dcc965148ed98,
title = "Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability",
abstract = "Germline mutations in nuclear genes encoding mitochondrial enzymes fumarate hydratase (FH) and succinate dehydrogenase (subunits SDHB/C/D) have been implicated in the development of tumor syndromes referred to as hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary paragangliomatosis (HPGL), respectively. FH and SDH are operating in the tricarboxylic acid cycle (the TCA cycle, the Krebs cycle). In the FH and SDH deficient tumors, accumulation of the substrates, fumarate and succinate, has been shown to cause stabilization of hypoxia inducible factor 1α (HIF1α). According to recent studies, HIF1α could contribute to the hypoxia induced genomic instability seen in many cancers, through repression of mismatch repair (MMR) protein MSH2. In this study, in agreement with previous works, we found HIF1α to be moderately or highly stabilized in 67{\%} (16/24) and 77{\%} (48/62) of HLRCC tumors and SDHB/C/D paragangliomas (PGL) and pheochromocytomas (PHEO), respectively. In addition, a set of 54 other familial and nonfamilial PGLs/PHEOs were studied. Moderately or highly stabilized HIF1α was present in 68{\%} (26/38) of the PGLs but in PHEOs (n = 16) no such pattern was observed. We then analyzed the suggested link between HIF1α stabilization and MSH2 repression, in HLRCC and HPGL tumor material. No microsatellite instability (MSI) or lack of MSH2 expression was, however, observed. Thus we failed to provide in vivo evidence for the proposed link between HIF1α stabilization and functional MMR deficiency, in TCAC deficient tumors.",
keywords = "Fumarate hydratase, HIF1, Microsatellite instability, MSH2, Succinate dehydrogenase",
author = "Lehtonen, {Heli J.} and M{\"a}kinen, {Markus J.} and Kiuru, {Maija Ht} and P{\"a}ivi Laiho and Riitta Herva and {Van Minderhout}, Ivonne and Hogendoorn, {Pancras C.W.} and Cees Cornelisse and Peter Devilee and Virpi Launonen and Aaltonen, {Lauri A.}",
year = "2007",
month = "9",
day = "15",
doi = "10.1002/ijc.22819",
language = "English (US)",
volume = "121",
pages = "1386--1389",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability

AU - Lehtonen, Heli J.

AU - Mäkinen, Markus J.

AU - Kiuru, Maija Ht

AU - Laiho, Päivi

AU - Herva, Riitta

AU - Van Minderhout, Ivonne

AU - Hogendoorn, Pancras C.W.

AU - Cornelisse, Cees

AU - Devilee, Peter

AU - Launonen, Virpi

AU - Aaltonen, Lauri A.

PY - 2007/9/15

Y1 - 2007/9/15

N2 - Germline mutations in nuclear genes encoding mitochondrial enzymes fumarate hydratase (FH) and succinate dehydrogenase (subunits SDHB/C/D) have been implicated in the development of tumor syndromes referred to as hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary paragangliomatosis (HPGL), respectively. FH and SDH are operating in the tricarboxylic acid cycle (the TCA cycle, the Krebs cycle). In the FH and SDH deficient tumors, accumulation of the substrates, fumarate and succinate, has been shown to cause stabilization of hypoxia inducible factor 1α (HIF1α). According to recent studies, HIF1α could contribute to the hypoxia induced genomic instability seen in many cancers, through repression of mismatch repair (MMR) protein MSH2. In this study, in agreement with previous works, we found HIF1α to be moderately or highly stabilized in 67% (16/24) and 77% (48/62) of HLRCC tumors and SDHB/C/D paragangliomas (PGL) and pheochromocytomas (PHEO), respectively. In addition, a set of 54 other familial and nonfamilial PGLs/PHEOs were studied. Moderately or highly stabilized HIF1α was present in 68% (26/38) of the PGLs but in PHEOs (n = 16) no such pattern was observed. We then analyzed the suggested link between HIF1α stabilization and MSH2 repression, in HLRCC and HPGL tumor material. No microsatellite instability (MSI) or lack of MSH2 expression was, however, observed. Thus we failed to provide in vivo evidence for the proposed link between HIF1α stabilization and functional MMR deficiency, in TCAC deficient tumors.

AB - Germline mutations in nuclear genes encoding mitochondrial enzymes fumarate hydratase (FH) and succinate dehydrogenase (subunits SDHB/C/D) have been implicated in the development of tumor syndromes referred to as hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary paragangliomatosis (HPGL), respectively. FH and SDH are operating in the tricarboxylic acid cycle (the TCA cycle, the Krebs cycle). In the FH and SDH deficient tumors, accumulation of the substrates, fumarate and succinate, has been shown to cause stabilization of hypoxia inducible factor 1α (HIF1α). According to recent studies, HIF1α could contribute to the hypoxia induced genomic instability seen in many cancers, through repression of mismatch repair (MMR) protein MSH2. In this study, in agreement with previous works, we found HIF1α to be moderately or highly stabilized in 67% (16/24) and 77% (48/62) of HLRCC tumors and SDHB/C/D paragangliomas (PGL) and pheochromocytomas (PHEO), respectively. In addition, a set of 54 other familial and nonfamilial PGLs/PHEOs were studied. Moderately or highly stabilized HIF1α was present in 68% (26/38) of the PGLs but in PHEOs (n = 16) no such pattern was observed. We then analyzed the suggested link between HIF1α stabilization and MSH2 repression, in HLRCC and HPGL tumor material. No microsatellite instability (MSI) or lack of MSH2 expression was, however, observed. Thus we failed to provide in vivo evidence for the proposed link between HIF1α stabilization and functional MMR deficiency, in TCAC deficient tumors.

KW - Fumarate hydratase

KW - HIF1

KW - Microsatellite instability

KW - MSH2

KW - Succinate dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=34548086488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548086488&partnerID=8YFLogxK

U2 - 10.1002/ijc.22819

DO - 10.1002/ijc.22819

M3 - Article

VL - 121

SP - 1386

EP - 1389

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -